Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George Coukos

Showing results (61-70 of 355) with videos related to

Pageof 36
Sort By:
Frontiers in Immunology|November 7, 2017
'Hotspots' of Antigen Presentation Revealed by Human Leukocyte Antigen Ligandomics for Neoantigen PrioritizationMarkus Müller, David Gfeller, George Coukos, et al.
Cancer Metastasis Reviews|February 8, 2011
Tumor immune surveillance and ovarian cancer: lessons on immune mediated tumor rejection or toleranceLana E Kandalaft, Gregory T Motz, Jaikumar Duraiswamy, et al.
Cancer Biology & Therapy|May 7, 2008
Herpes virus oncolytic therapy reverses tumor immune dysfunction and facilitates tumor antigen presentationFabian Benencia, Maria C Courrèges, Nigel W Fraser, et al.
Advances in Experimental Medicine and Biology|June 13, 2008
Inhibitory B7 family members in human ovarian carcinomaShuang Wei, Tyler Curiel, George Coukos, et al.
Frontiers in Immunology|July 28, 2020
Cancer and HIV-1 Infection: Patterns of Chronic Antigen ExposureSelena Vigano, Sara Bobisse, George Coukos, et al.
Current Topics in Microbiology and Immunology|August 4, 2010
Angiogenesis and the tumor vasculature as antitumor immune modulators: the role of vascular endothelial growth factor and endothelinLana E Kandalaft, Gregory T Motz, Johanna Busch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 17, 2010
Immunotherapy for ovarian cancer: what's next?Lana E Kandalaft, Daniel J Powell, Nathan Singh, et al.
Advances in Experimental Medicine and Biology|June 13, 2008
Role of vascular leukocytes in ovarian cancer neovascularizationKlara Balint, Jose R Conejo-Garcia, Ron Buckanovich, et al.
Expert Opinion on Biological Therapy|August 31, 2007
miRNA genetic alterations in human cancersAntonis Giannakakis, George Coukos, Artemis Hatzigeorgiou, et al.
Therapeutic Advances in Medical Oncology|May 17, 2021
Cell therapies in ovarian cancerApostolos Sarivalasis, Matteo Morotti, Arthur Mulvey, et al.
Pageof 36

Showing results (61-70 of 355) with videos related to

Sort By:
Pageof 36
Frontiers in Immunology|November 7, 2017
'Hotspots' of Antigen Presentation Revealed by Human Leukocyte Antigen Ligandomics for Neoantigen PrioritizationMarkus Müller, David Gfeller, George Coukos, et al.
Cancer Metastasis Reviews|February 8, 2011
Tumor immune surveillance and ovarian cancer: lessons on immune mediated tumor rejection or toleranceLana E Kandalaft, Gregory T Motz, Jaikumar Duraiswamy, et al.
Cancer Biology & Therapy|May 7, 2008
Herpes virus oncolytic therapy reverses tumor immune dysfunction and facilitates tumor antigen presentationFabian Benencia, Maria C Courrèges, Nigel W Fraser, et al.
Advances in Experimental Medicine and Biology|June 13, 2008
Inhibitory B7 family members in human ovarian carcinomaShuang Wei, Tyler Curiel, George Coukos, et al.
Frontiers in Immunology|July 28, 2020
Cancer and HIV-1 Infection: Patterns of Chronic Antigen ExposureSelena Vigano, Sara Bobisse, George Coukos, et al.
Current Topics in Microbiology and Immunology|August 4, 2010
Angiogenesis and the tumor vasculature as antitumor immune modulators: the role of vascular endothelial growth factor and endothelinLana E Kandalaft, Gregory T Motz, Johanna Busch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 17, 2010
Immunotherapy for ovarian cancer: what's next?Lana E Kandalaft, Daniel J Powell, Nathan Singh, et al.
Advances in Experimental Medicine and Biology|June 13, 2008
Role of vascular leukocytes in ovarian cancer neovascularizationKlara Balint, Jose R Conejo-Garcia, Ron Buckanovich, et al.
Expert Opinion on Biological Therapy|August 31, 2007
miRNA genetic alterations in human cancersAntonis Giannakakis, George Coukos, Artemis Hatzigeorgiou, et al.
Therapeutic Advances in Medical Oncology|May 17, 2021
Cell therapies in ovarian cancerApostolos Sarivalasis, Matteo Morotti, Arthur Mulvey, et al.
Pageof 36